ERBB2 and cholangiocarcinoma: Other epithelial-origin tumors, including colorectal cancer (CRC), esophageal, bladder, cholangiocarcinoma, gallbladder, cervical, and endometrial cancers, also demonstrate HER2 IHC overexpression.5–7